Chimeric Antigen Receptor-Modified T Cell Therapy in Multiple Myeloma: Beyond B Cell Maturation Antigen-Reference-Cited by-同舟云学术

Chimeric Antigen Receptor-Modified T Cell Therapy in Multiple Myeloma: Beyond B Cell Maturation Antigen

Published:2019-07-16 Issue: Volume:10 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Timmers Marijke,Roex Gils,Wang Yuedi,Campillo-Davo Diana,Van Tendeloo Viggo F. I.,Chu Yiwei,Berneman Zwi N.,Luo Feifei,Van Acker Heleen H.,Anguille Sébastien

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference114 articles.

1. Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN);Palumbo;Blood.,2011

2. Multiple myeloma: evolving genetic events and host interactions;Kuehl;Nat Rev Cancer.,2002

3. Multiple myeloma;Palumbo;N Engl J Med.,2011

4. Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor;Kochenderfer;J Clin Oncol.,2015

5. CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia;Maude;Blood.,2015

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the efficacy and safety of anti-BCMA chimeric antigen receptor T-cell therapy for multiple myeloma: Systematic review and meta-analysis;Cytojournal;2024-03-18

2. CAR T therapies in multiple myeloma: unleashing the future;Cancer Gene Therapy;2024-03-04

3. Transient acute kidney injury after chimeric antigen receptor T-cell therapy in patients with hematological malignancies;Clinical Kidney Journal;2024-02-20

4. How does time speak about cancer, its diagnosis, treatments, and challenges?;Biomarkers in Cancer Detection and Monitoring of Therapeutics;2024

5. Advancements in CRISPR screens for the development of cancer immunotherapy strategies;Molecular Therapy - Oncolytics;2023-12